The effect of sulphydryl and enzyme inhibitors on platelet aggregation in vitro.
D000227:Adenine Nucleotides / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000494:pharmacology; D001777:Blood Coagulation / Q000187:drug effects*; D001792:Blood Platelets / Q000187:drug effects*; D003486:Cyanides / Q000494:pharmacology; D003545:Cysteine / Q000494:pharmacology; D003720:Densitometry; D003864:Depression, Chemical; D004492:Edetic Acid / Q000494:pharmacology; D004791:Enzyme Inhibitors; D005033:Ethylmaleimide / Q000494:pharmacology; D005459:Fluorides / Q000494:pharmacology; D005463:Fluoroacetates / Q000494:pharmacology; D006019:Glycolysis / Q000187:drug effects*; D006801:Humans; D008628:Mercury / Q000494:pharmacology; D013438:Sulfhydryl Compounds
D000227:Adenine Nucleotides; D003486:Cyanides; D004791:Enzyme Inhibitors; D005463:Fluoroacetates; D013438:Sulfhydryl Compounds; D000255:Adenosine Triphosphate; D004492:Edetic Acid; D008628:Mercury; D003545:Cysteine; D005033:Ethylmaleimide; D005459:Fluorides